20
Participants
Start Date
April 30, 2009
Primary Completion Date
June 4, 2014
Study Completion Date
June 4, 2014
regadenoson
Subjects in open label group will be given a single dose of regadenoson (0.4 mg, i.e. 5 ml i.v. bolus) as contrast.
University of Chicago, Chicago
Collaborators (1)
Astellas Pharma Inc
INDUSTRY
University of Chicago
OTHER